Ep. 150. Sarah Gallo: CBA and FDA—Modernizing Recalls, Inspections, Labeling, and More
Ep. 150. Sarah Gallo: CBA and FDA—Modernizing Recalls, Inspections, Labeling, and More

Ep. 150. Sarah Gallo: CBA and FDA—Modernizing Recalls, Inspections, Labeling, and More

WynMarquez

55 min
Success & Inspiration
Play

Description

<p class="MsoNormal" style="margin-top: 4.0pt;"><span style= "font-size: 12pt;"><strong style= "mso-bidi-font-weight: normal;"><span lang="EN" style= "mso-ansi-language: EN;" xml:lang="EN">Sarah Gallo</span></strong> <span lang="EN" style="mso-ansi-language: EN;" xml:lang="EN">is Vice President of Product Policy at the Consumer Brands Association (CBA). In her role, Sarah holistically oversees Consumer Brands' policy leadership on smart regulation issues, from advocacy through education to marketplace solutions. Prior to joining CBA, she served as Vice President of Agriculture and Environment for the Biotechnology Innovation Organization, where she led the organization's strategy across agriculture, food systems, energy, and bio-based manufacturing. Earlier in Sarah’s career, she held roles at CHS Inc. and the National Corn Growers Association and served as Agriculture Counsel with the U.S. House of Representatives Committee on Small Business. She graduated from Boston University with a B.A. in Marine Biology.</span></span></p> <p class="MsoNormal" style="margin-top: 4.0pt;"><span style= "font-size: 12pt;"><strong style="mso-bidi-font-weight: normal;">In this episode of <em style="mso-bidi-font-style: normal;">Food Safety Matters</em>, we speak with Sarah</strong> [24:28] <strong style= "mso-bidi-font-weight: normal;">about:</strong></span></p> <ul> <li class="MsoNormal"><span style="font-size: 12pt;"><span style= "mso-bidi-font-weight: bold;">CBA’s key recommendations for FDA during its restructuring, and how those suggestions are<span style= "mso-spacerun: yes;"> </span> informed by looking at FDA modernization through the lens of the consumer</span></span></li> <li class="MsoNormal"><span style="font-size: 12pt;"><span style= "mso-bidi-font-weight: bold;">Specific changes that CBA believes could help FDA transition from one-size-fits-all inspections to a tailored, risk-based model for inspections</span></span></li> <li class="MsoNormal"><span style="font-size: 12pt;"> <!--[endif]--><span style="mso-bidi-font-w

Uploader

tia_sun

tia_sun

Ep. 150. Sarah Gallo: CBA and FDA—Modernizing Recalls, Inspections, Labeling, and More - Listen Free | WowFM